Kharofa JR - Search Results

1

Systemic Therapy for Resected Pancreatic Adenocarcinoma: How Much is Enough?

Turner KM, Delman AM, Vaysburg DM, Kharofa JR, Smith MT, Choe KA, Olowokure O, Sohal D, Wilson GC, Ahmad SA, Patel SH. Turner KM, et al. Among authors: kharofa jr. Ann Surg Oncol. 2022 Jun;29(6):3463-3472. doi: 10.1245/s10434-022-11363-0. Epub 2022 Feb 9. Ann Surg Oncol. 2022. PMID: 35141802

2

Neoadjuvant chemoradiation with IMRT in resectable and borderline resectable pancreatic cancer.

Kharofa J, Tsai S, Kelly T, Wood C, George B, Ritch P, Wiebe L, Christians K, Evans DB, Erickson B. Kharofa J, et al. Radiother Oncol. 2014 Oct;113(1):41-6. doi: 10.1016/j.radonc.2014.09.010. Epub 2014 Oct 15. Radiother Oncol. 2014. PMID: 25443499 Free PMC article.

3

Does radiologic response correlate to pathologic response in patients undergoing neoadjuvant therapy for borderline resectable pancreatic malignancy?

Xia BT, Fu B, Wang J, Kim Y, Ahmad SA, Dhar VK, Levinsky NC, Hanseman DJ, Habib DA, Wilson GC, Smith M, Olowokure OO, Kharofa J, Al Humaidi AH, Choe KA, Abbott DE, Ahmad SA. Xia BT, et al. J Surg Oncol. 2017 Mar;115(4):376-383. doi: 10.1002/jso.24538. Epub 2017 Jan 20. J Surg Oncol. 2017. PMID: 28105634

4

Downstaging therapy followed by liver transplantation for hepatocellular carcinoma beyond Milan criteria.

Kim Y, Stahl CC, Makramalla A, Olowokure OO, Ristagno RL, Dhar VK, Schoech MR, Chadalavada S, Latif T, Kharofa J, Bari K, Shah SA. Kim Y, et al. Surgery. 2017 Dec;162(6):1250-1258. doi: 10.1016/j.surg.2017.08.007. Epub 2017 Oct 13. Surgery. 2017. PMID: 29033224

5

Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer.

Kharofa J, Mierzwa M, Olowokure O, Sussman J, Latif T, Gupta A, Xie C, Patel S, Esslinger H, Mcgill B, Wolf E, Ahmad SA. Kharofa J, et al. Am J Clin Oncol. 2019 Mar;42(3):247-252. doi: 10.1097/COC.0000000000000518. Am J Clin Oncol. 2019. PMID: 30724781 Clinical Trial.

6

[No title available]

[No authors listed] [No authors listed] PMID: 32568786

7

Patterns of Failure After Neoadjuvant Stereotactic Body Radiation Therapy or Fractionated Chemoradiation in Resectable and Borderline Resectable Pancreatic Cancer.

Barrord M, Ahmad S, Patel S, Olowokure O, Sussman J, Smith M, Poreddy S, Esslinger H, Latif T, Choe K, Kharofa J. Barrord M, et al. Pancreas. 2020 Aug;49(7):941-946. doi: 10.1097/MPA.0000000000001602. Pancreas. 2020. PMID: 32658077

8

Comparison of Radiation Treatment Volumes for Borderline Resectable Pancreatic Cancer in Contemporary Clinical Trials.

Bluemel TS, Kharofa J. Bluemel TS, et al. Am J Clin Oncol. 2020 Sep;43(9):648-653. doi: 10.1097/COC.0000000000000726. Am J Clin Oncol. 2020. PMID: 32889835

9

Evaluating the Impact of ESPAC-1 on Shifting the Paradigm of Pancreatic Cancer Treatment.

Winer LK, Cortez AR, Ahmad SA, Wima K, Olowokure O, Latif T, Kharofa J, Patel SH. Winer LK, et al. J Surg Res. 2021 Mar;259:442-450. doi: 10.1016/j.jss.2020.09.009. Epub 2020 Oct 13. J Surg Res. 2021. PMID: 33059910

10

Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.

Thompson MA, Henderson JP, Shah PK, Rubinstein SM, Joyner MJ, Choueiri TK, Flora DB, Griffiths EA, Gulati AP, Hwang C, Koshkin VS, Papadopoulos EB, Robilotti EV, Su CT, Wulff-Burchfield EM, Xie Z, Yu PP, Mishra S, Senefeld JW, Shah DP, Warner JL; COVID-19 and Cancer Consortium. Thompson MA, et al. JAMA Oncol. 2021 Jun 17;7(8):1167-75. doi: 10.1001/jamaoncol.2021.1799. Online ahead of print. JAMA Oncol. 2021. PMID: 34137799 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

74 results

Search Page